Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950

SE Corcoran, R Halai, MA Cooper - Pharmacological reviews, 2021 - ASPET
Activation of the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome
drives release of the proinflammatory cytokines interleukin (IL)-1 β and IL-18 and induces …

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

ME Haque, M Akther, M Jakaria, IS Kim… - Movement …, 2020 - Wiley Online Library
Excessive activation of microglia and subsequent release of proinflammatory cytokines play
a crucial role in neuroinflammation and neurodegeneration in Parkinson's disease (PD) …

[HTML][HTML] The NLRP3 inflammasome: an emerging therapeutic target for chronic pain

R Chen, C Yin, J Fang, B Liu - Journal of neuroinflammation, 2021 - Springer
Chronic pain affects the life quality of the suffering patients and posts heavy problems to the
health care system. Conventional medications are usually insufficient for chronic pain …

NLRP3 inflammasome in neurodegenerative disease

FL Anderson, KE Biggs, BE Rankin, MC Havrda - Translational Research, 2023 - Elsevier
Neurodegenerative diseases are characterized by a dysregulated neuro-glial
microenvironment, culminating in functional deficits resulting from neuronal cell death …

[HTML][HTML] Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets

V Govindarajan, JP de Rivero Vaccari… - Journal of …, 2020 - Springer
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS), and
it remains the most common immune-mediated disorder affecting the CNS. While the cause …

[HTML][HTML] Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): relevant signaling pathways and therapeutic …

J Jin, J Duan, L Du, W Xing, X Peng… - Frontiers in …, 2022 - frontiersin.org
Intracranial aneurysm subarachnoid hemorrhage (SAH) is a cerebrovascular disorder
associated with high overall mortality. Currently, the underlying mechanisms of pathological …

Neuroinflammation mediated by NLRP3 inflammasome after intracerebral hemorrhage and potential therapeutic targets

L Xiao, H Zheng, J Li, Q Wang, H Sun - Molecular Neurobiology, 2020 - Springer
Intracerebral hemorrhage (ICH) is the most fatal subtype of stroke; there is still a lack of
effective treatment. Microglia are a major component of the innate immune system, and they …

[HTML][HTML] NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes

D Dutta, J Liu, H Xiong - International journal of physiology …, 2022 - ncbi.nlm.nih.gov
Despite the introduction of vaccines and drugs for SARS-CoV-2, the COVID-19 pandemic
continues to spread throughout the world. In severe COVID-19 patients, elevated levels of …

[HTML][HTML] OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis

A Sánchez-Fernández, DB Skouras… - Frontiers in …, 2019 - frontiersin.org
IL-1β and IL-18 are pro-inflammatory cytokines that are linked to inflammation. Activation of
the NOD-like receptor protein 3 (NLRP3) inflammasome is involved in the maturation and …

[HTML][HTML] The NLRP3 inflammasome: role and therapeutic potential in pain treatment

H Starobova, EI Nadar, I Vetter - Frontiers in Physiology, 2020 - frontiersin.org
Pain is a fundamental feature of inflammation. The immune system plays a critical role in the
activation of sensory neurons and there is increasing evidence of neuro-inflammatory …